| Basics |
|
Repare Therapeutics Inc.
|
| IPO Date: |
May 2, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$95.21M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.42 | 3.10%
|
| Avg Daily Range (30 D): |
$0.04 | 2.28%
|
| Avg Daily Range (90 D): |
$0.03 | 1.83%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.21M |
| Avg Daily Volume (30 D): |
.77M |
| Avg Daily Volume (90 D): |
.33M |
| Trade Size |
| Avg Trade Size (Sh.): |
117 |
| Avg Trade Size (Sh.) (30 D): |
310 |
| Avg Trade Size (Sh.) (90 D): |
304 |
| Institutional Trades |
| Total Inst.Trades: |
58 |
| Avg Inst. Trade: |
$1.57M |
| Avg Inst. Trade (30 D): |
$.91M |
| Avg Inst. Trade (90 D): |
$.91M |
| Avg Inst. Trade Volume: |
.21M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.49M |
| Avg Closing Trade (30 D): |
$2.61M |
| Avg Closing Trade (90 D): |
$2.61M |
| Avg Closing Volume: |
162.82K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$.08
|
$-.39
|
|
Diluted EPS
|
|
$.08
|
$-.39
|
|
Revenue
|
$
|
$ 15.01M
|
$ 5.92M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ 3.26M
|
$ -16.74M
|
|
Operating Income / Loss
|
$
|
$ 1.13M
|
$ -17.78M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ 5.17M
|
$ -16.8M
|
|
PE Ratio
|
|
|
|
|
|
|